Skip to main content
Premium Trial:

Request an Annual Quote

Michael French, Alexander Makarov

Premium
MDRNA, formerly Nastech Pharmaceutical, has appointed Michael French as its CEO.
 
French previously served as senior vice president of corporate development at Sirna Therapeutics. Before that, he was CBO of biotech firm Entelos.
 
He holds an MS in physiology and biophysics from Georgetown University and a BS in aerospace engineering from the United States Military Academy.
 

 
Alexander Makarov, director of global research for life sciences mass spectrometry at Thermo Fisher Scientific, has received the 2008 Distinguished Contribution in Mass Spectrometry Award from the American Society for Mass Spectrometry.
 
Makarov was a research fellow at the University of Warwick, Coventry, UK, and he was a senior scientific researcher at the Russian Academy of Sciences in Moscow.